Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01353716
What this trial is testing

Dolutegravir Renal Impairment Study

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 16
Large-scale testing (Phase 3)Study completedNCT00124098
What this trial is testing

An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

Who this might be right for
Kidney Disease
Amgen
Early research (Phase 1)Ended earlyNCT02508740
What this trial is testing

Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Who this might be right for
Renal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04020055
What this trial is testing

Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 14
Early research (Phase 1)Study completedNCT04849650
What this trial is testing

PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment

Who this might be right for
Renal Disease, End Stage
Acacia Pharma Ltd 12
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT02128490
What this trial is testing

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

Who this might be right for
GoutModerate Renal Impairment
Takeda 189
Early research (Phase 1)Study completedNCT00750620
What this trial is testing

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Astellas Pharma Inc 33
Early research (Phase 1)Study completedNCT05515458
What this trial is testing

Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Chipscreen Biosciences, Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT01977573
What this trial is testing

Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

Who this might be right for
Anaemia
GlaxoSmithKline 252
Early research (Phase 1)Study completedNCT01367509
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function

Who this might be right for
Renal Impairment
Bausch Health Americas, Inc. 32
Post-approval studies (Phase 4)Ended earlyNCT00584779
What this trial is testing

An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis

Who this might be right for
PK Properties Of Gabapentin In Subjects With Impaired Renal Function
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT00240734
What this trial is testing

Treatment of Anemia in Diabetic Subjects With CKD

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 11
Post-approval studies (Phase 4)Ended earlyNCT00062699
What this trial is testing

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

Who this might be right for
End-Stage Kidney Disease
Abbott 2,200
Testing effectiveness (Phase 2)Ended earlyNCT00150319
What this trial is testing

An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend

Who this might be right for
Kidney Failure
Pfizer 1
Large-scale testing (Phase 3)Study completedNCT00116701
What this trial is testing

Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis

Who this might be right for
Kidney Disease
Amgen 200
Early research (Phase 1)Study completedNCT01555008
What this trial is testing

Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Lexicon Pharmaceuticals 31
Early research (Phase 1)Study completedNCT01290029
What this trial is testing

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseHyperparathyroidism, SecondarySecondary Hyperparathyroidism
Amgen 14
Testing effectiveness (Phase 2)Study completedNCT00817037
What this trial is testing

Sitaxsentan in Proteinuric Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseProteinuriaBlood Pressure
University of Edinburgh 27
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation